Frontiers Association of Lipoprotein(a)-Associated Mortality and

Frontiers Association of Lipoprotein(a)-Associated Mortality and the Estimated Glomerular Filtration Rate Level in Patients Undergoing Coronary Angiography: A 51,500 Cohort Study

Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease

Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association

Lipoprotein(a) and Cardiovascular Disease

Frontiers Serum lipoprotein (a) associates with the risk of renal function damage in the CHCN-BTH Study: Cross-sectional and Mendelian randomization analyses

Predictive value of lipoprotein(a) in coronary artery calcification among asymptomatic cardiovascular disease subjects: A systematic review and meta-analysis - ScienceDirect

Frontiers HDL Composition, Heart Failure, and Its Comorbidities

The role of Lipoprotein(a) in cardiovascular disease: Current concepts and future perspectives - ScienceDirect

Full article: A Non-Linear Association of High-Density Lipoprotein Cholesterol with All-Cause and Cause-Specific Mortality in Diabetic Patients

IJERPH, Free Full-Text

Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study - The Lancet Diabetes & Endocrinology

Levels of lipoprotein (a) with respect to Gensini scores and no-reflow.

Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome